Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.014 AUD -0.00 ( 6.67%)
Last update at 2026-11-12T02:40:00Z
VOLUME
1693188
Market Cap
20.27M

Momentum Score

…

Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.07
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Pathkey.ai Ltd (ASX:PKY) is limited; available disclosures do not clearly describe its core products, customers, or financials. If it operates in artificial intelligence or related software, long-term growth may depend on enterprise AI adoption, scalable recurring revenue and successful commercialization, which could appeal to investors seeking early-stage AI exposure but hinge on execution.
Material risks include the company's limited public disclosure and likely early‑stage profile with execution and financing risk, low liquidity, competitive pressures in AI markets, and potential regulatory or technological obsolescence.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.05M
Revenue Per Share
-
Gross Profit TTM
-0.19M
Debt / Equity
1.12
ROE
-18.46%
Net Debt
-3.41M
ROCE
-9.69%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -3.86M -1.45M -3.13M -1.73M -2.30M
Net income -3.65M -1.45M -3.13M -1.73M -1.73M
Selling general administrative - 1.32M 3.32M 2.67M 1.07M
Selling and marketing expenses - - - - 0.06M
Gross profit -2.81M - - - -0.93M
Ebit -3.86M - - - -2.29M
Ebitda -3.85M - - - -2.27M
Depreciation and amortization 0.01M - - - 0.03M
Operating income -3.86M -1.67M -3.23M -2.33M -2.33M
Other operating expenses 3.91M - - - 2.95M
Interest expense - - - - 0.00M
Tax provision - 0.00M 0.00M 0.00M -
Interest income - 0.07M 0.43M 0.00M -
Income tax expense -0.21M - - - -0.57M
Total revenue 0.05M 0.03M 0.40M 0.62M 0.62M
Total operating expenses 1.05M 1.69M 3.62M 2.95M 1.29M
Cost of revenue 2.86M - - - 1.55M
Total other income expense net -0.00M - - - 0.03M
Net income applicable to common shares - -1.45M -3.13M -1.73M -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 40.31M 0.51M 0.41M 0.71M 0.71M
Intangible assets 36.73M - 0.00M 0.02M 0.02M
Other current assets 0.07M 0.00M 0.01M - -0.33M
Total liab 0.47M 0.78M 0.50M 1.11M 0.71M
Total stockholder equity 39.84M -0.27M -0.09M -0.40M 0.27M
Other current liab 0.22M - - - 0.07M
Common stock 57.97M 23.64M 22.50M 19.92M 19.27M
Retained earnings -28.55M -23.91M -22.59M -20.32M -19.37M
Other assets - 0.00M 0.01M - -
Cash 3.41M - - - 0.45M
Cash and equivalents - 0.11M 0.37M 0.45M -
Total current liabilities 0.47M 0.78M 0.50M 1.10M 0.68M
Current deferred revenue - - - - 0.13M
Net debt -3.41M - - - -0.15M
Short term debt - 0.41M 0.00M 0.30M 0.30M
Short long term debt total - - - - 0.30M
Property plant equipment - 0.02M 0.02M 0.01M -
Total current assets 3.57M 0.50M 0.39M 0.67M 0.67M
Short term investments - 0.33M - - -
Net receivables 0.09M 0.06M 0.01M 0.22M 0.22M
Accounts payable 0.26M - - - 0.17M
Accumulated other comprehensive income 10.42M - - - 0.37M
Non current assets total 36.74M - - - 0.04M
Long term debt total - 0.00M 0.00M 0.00M -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total cashflows from investing activities -0.17M -0.33M -0.02M -0.00M -0.01M
Total cash from financing activities 4.52M 1.35M 2.00M 1.03M 0.00M
Net income -3.65M -1.45M -3.13M - -
Change in cash 3.30M -0.27M -0.08M -0.33M -1.53M
Begin period cash flow 0.11M 0.37M 0.45M - -
End period cash flow 3.41M 0.11M 0.37M - -
Total cash from operating activities -1.05M -1.28M -2.06M -1.36M -1.52M
Depreciation 0.01M 0.01M - - -
Other cashflows from investing activities -0.06M - - - -
Change to account receivables -0.03M -0.05M 0.23M - -
Sale purchase of stock - - -0.19M 0.96M 0.00M
Other cashflows from financing activities - - -0.00M -0.07M 0.00M
Capital expenditures 0.00M 0.00M 0.02M 0.00M 0.01M
Change in working capital -0.15M -0.17M -0.07M 0.61M 0.36M
Other non cash items 2.75M 0.33M 1.15M - -
Free cash flow -1.05M -1.29M -2.07M - -

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PKY
Pathkey.ai Ltd
-0.00
6.67%
0.01 - 7.03 425.63 0.51 445.83 -0.68
PME
Pro Medicus Ltd
-4.52
2.18%
202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd
-0.06
2.53%
2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd
0.12
3.30%
3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd
-0.14
3.91%
3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Pathkey.ai Ltd

Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.

Level 12, Sydney, NSW, Australia, 2000

61 3 9923 1222

Name Title Year Born
Mr. Saurabh Jain CEO & Executive Chairman NA
Mr. Damon Rasheed CTO & Executive Director NA
Mr. Mark Ziirsen Chief Financial Officer 1963
Bernice Averion Head of Marketing & Communications NA
Mr. Shane Lewis Vice President of Sales & Partnerships NA
Mr. Matt Hallam Chief Revenue Officer NA
Mr. Jonathan Hart B.Com., L.L.B. Company Secretary 1984
Mr. Damon Rasheed CTO & Executive Chairman NA
Mr. Damon Rasheed Founder, CTO & Executive Director NA
Mr. Andrew Farnsworth Chief Executive Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…